IFM Investors Pty Ltd increased its holdings in shares of Colgate-Palmolive (NYSE:CL) by 12.5% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 67,952 shares of the company’s stock after purchasing an additional 7,534 shares during the period. IFM Investors Pty Ltd’s holdings in Colgate-Palmolive were worth $5,242,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also modified their holdings of the stock. Reynders McVeigh Capital Management LLC raised its holdings in shares of Colgate-Palmolive by 1.3% during the second quarter. Reynders McVeigh Capital Management LLC now owns 10,487 shares of the company’s stock worth $768,000 after purchasing an additional 134 shares during the last quarter. Stephens Inc. AR raised its holdings in shares of Colgate-Palmolive by 0.3% during the second quarter. Stephens Inc. AR now owns 42,252 shares of the company’s stock worth $3,095,000 after purchasing an additional 134 shares during the last quarter. Valeo Financial Advisors LLC raised its holdings in shares of Colgate-Palmolive by 3.4% during the second quarter. Valeo Financial Advisors LLC now owns 4,128 shares of the company’s stock worth $302,000 after purchasing an additional 135 shares during the last quarter. Capital Insight Partners LLC raised its holdings in shares of Colgate-Palmolive by 0.6% during the second quarter. Capital Insight Partners LLC now owns 21,635 shares of the company’s stock worth $1,585,000 after purchasing an additional 137 shares during the last quarter. Finally, Aries Wealth Management raised its holdings in shares of Colgate-Palmolive by 0.9% during the third quarter. Aries Wealth Management now owns 16,126 shares of the company’s stock worth $1,244,000 after purchasing an additional 140 shares during the last quarter. 76.74% of the stock is owned by hedge funds and other institutional investors.

CL traded up $0.60 on Friday, reaching $80.31. 2,963,577 shares of the company’s stock were exchanged, compared to its average volume of 4,302,619. The stock has a market cap of $68.86 billion, a PE ratio of 26.86, a P/E/G ratio of 4.63 and a beta of 0.59. Colgate-Palmolive has a twelve month low of $58.49 and a twelve month high of $80.99. The stock’s fifty day moving average price is $77.55 and its 200-day moving average price is $73.84. The company has a debt-to-equity ratio of 9.40, a current ratio of 0.92 and a quick ratio of 0.59.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, July 31st. The company reported $0.74 earnings per share for the quarter, topping analysts’ consensus estimates of $0.69 by $0.05. The firm had revenue of $3.90 billion for the quarter, compared to analyst estimates of $3.78 billion. Colgate-Palmolive had a net margin of 16.13% and a return on equity of 559.34%. Colgate-Palmolive’s quarterly revenue was up .8% on a year-over-year basis. During the same period in the previous year, the business posted $0.72 earnings per share. As a group, research analysts predict that Colgate-Palmolive will post 2.96 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Monday, November 16th. Investors of record on Friday, October 23rd will be given a dividend of $0.44 per share. The ex-dividend date is Thursday, October 22nd. This represents a $1.76 dividend on an annualized basis and a yield of 2.19%. Colgate-Palmolive’s payout ratio is presently 62.19%.

In other Colgate-Palmolive news, SVP John J. Huston sold 84,905 shares of Colgate-Palmolive stock in a transaction dated Wednesday, August 12th. The shares were sold at an average price of $77.18, for a total transaction of $6,552,967.90. Following the transaction, the senior vice president now directly owns 82,988 shares of the company’s stock, valued at $6,405,013.84. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Philip G. Shotts sold 401 shares of Colgate-Palmolive stock in a transaction dated Monday, September 28th. The stock was sold at an average price of $77.29, for a total transaction of $30,993.29. Following the transaction, the vice president now directly owns 41,263 shares in the company, valued at $3,189,217.27. The disclosure for this sale can be found here. Insiders have sold 256,994 shares of company stock worth $19,678,851 over the last 90 days. 0.78% of the stock is currently owned by company insiders.

CL has been the topic of several analyst reports. Morgan Stanley raised their price target on shares of Colgate-Palmolive from $78.00 to $80.00 and gave the company an “equal weight” rating in a research report on Monday, August 3rd. Deutsche Bank Aktiengesellschaft raised their price target on shares of Colgate-Palmolive from $75.00 to $78.00 and gave the company a “hold” rating in a research report on Monday, August 3rd. TheStreet upgraded shares of Colgate-Palmolive from a “c+” rating to a “b+” rating in a research report on Friday, July 31st. Finally, Royal Bank of Canada restated a “buy” rating and set a $88.00 price target on shares of Colgate-Palmolive in a research report on Thursday, July 30th. Three research analysts have rated the stock with a sell rating, four have assigned a hold rating and six have given a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average target price of $75.27.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.

See Also: Backdoor Roth IRA

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.